Jean Lang

Medicine · Health Sciences

45h-index7.0kcitations134works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mosquito-borne diseases and control(63), Viral Infections and Vectors(40), Rabies epidemiology and control(28), Malaria Research and Control(27), Viral Infections and Outbreaks Research(24)

Publications134 total

Titelei/Inhaltsverzeichnis
Nomos Verlagsgesellschaft mbH & Co. KG eBooks·2025
EE832 The Lifetime Return on Investment of Measles, Mumps, and Rubella Vaccination in Belgium and Poland
Value in Health·2024Open Access
EE50 Estimating the Clinical and Economic Outcomes of Universal Varicella and Herpes Zoster Vaccination in Belgium Using a Dynamic Transmission Model With Dynamic Population
Value in Health·2024
EE465 Modeling the Effects of Improving Varicella Vaccination Coverage Rates on Clinical and Economic Outcomes in Peru Over a 10-Year Time-Horizon
Value in Health·2024Open Access
Stability of Yellow Fever Virus under Recombinatory Pressure as Compared with Chikungunya Virus
UNC Libraries·2020Open Access
Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4
Journal of Virology·2018· 19 citedOpen Access
Immunsuppressive Wirkung von Sulforaphan auf primäre humane T-Zellen
Zeitschrift für Phytotherapie·2017
Spätabbrüche nach der 12. SSW gemäß §218a Abs. 2 StGB – Daten aus der Praxis des „Gießener Modells“
Geburtshilfe und Frauenheilkunde·2016
Vaccination Against Dengue: Challenges and Current Developments
Annual Review of Medicine·2015· 53 cited
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
Vaccine·2015· 158 citedOpen Access
Dominance of HLA-B restricted virus-specific CD8+ T cell epitopes in chronic HBV infection
Zeitschrift für Gastroenterologie·2015
Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
Human Vaccines & Immunotherapeutics·2014· 33 citedOpen Access
Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus
Viruses·2013· 54 citedOpen Access
Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore
Human Vaccines & Immunotherapeutics·2013· 50 citedOpen Access
Efficacy of tetravalent dengue vaccine in Thai schoolchildren – Authors' reply
The Lancet·2013· 9 citedOpen Access
Verlust an Quality adjusted lifeyears (QALY) nach einer PCB-Exposition von Arbeitern eines Recycling-Betriebes, deren Familienangehörigen und Beschäftigten umliegender Firmen
DMW - Deutsche Medizinische Wochenschrift·2012· 1 cited
Q&A session 06 October 2011: I International Symposium on Dengue, FMUSP, São Paulo
Revista do Instituto de Medicina Tropical de São Paulo·2012Open Access
Development of Sanofi Pasteur tetravalent dengue vaccine
Revista do Instituto de Medicina Tropical de São Paulo·2012· 17 citedOpen Access
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
The Lancet·2012· 805 cited
Evaluation of Chimeric Yellow Fever 17D/Dengue Viral Replication in Ticks
Vector-Borne and Zoonotic Diseases·2012· 6 cited
page 1 of 7Next →

Frequent Co-authors

Bruno Guy(11), Rémi Forrat(11), Arunee Sabchareon(7), Thomas P. Monath(7), Pornthep Chanthavanich(6), Farshad Guirakhoo(6), Sutee Yoksan(6), Mélanie Saville(5), Krisana Pengsaa(4), B. Barrère(4), Laurent Chambonneau(4), Chukiat Sirivichayakul(3), Véronique Barban(3), Stephen Higgs(3), К. В. Пугачев(3), Nathan Brown(3), Richard Nichols(3), P. Attanath(3), Chanathep Pojjaroen‐Anant(3), Sarah Begue(3)